These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23089382)

  • 21. Synergistic regulation of the mouse orphan nuclear receptor SHP gene promoter by CLOCK-BMAL1 and LRH-1.
    Oiwa A; Kakizawa T; Miyamoto T; Yamashita K; Jiang W; Takeda T; Suzuki S; Hashizume K
    Biochem Biophys Res Commun; 2007 Feb; 353(4):895-901. PubMed ID: 17204240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological role of liver X receptors.
    Baranowski M
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Regulation of lipid metabolism by the orphan nuclear receptors].
    Lobaccaro JM; Repa JJ; Lu TT; Caira F; Henry-Berger J; Volle DH; Mangelsdorf DJ
    Ann Endocrinol (Paris); 2001 Jun; 62(3):239-47. PubMed ID: 11458177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver X receptors regulate adrenal steroidogenesis and hypothalamic-pituitary-adrenal feedback.
    Nilsson M; Stulnig TM; Lin CY; Yeo AL; Nowotny P; Liu ET; Steffensen KR
    Mol Endocrinol; 2007 Jan; 21(1):126-37. PubMed ID: 16973760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Na TY; Shin YK; Roh KJ; Kang SA; Hong I; Oh SJ; Seong JK; Park CK; Choi YL; Lee MO
    Hepatology; 2009 Apr; 49(4):1122-31. PubMed ID: 19105208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PXR and LXR in hepatic steatosis: a new dog and an old dog with new tricks.
    Lee JH; Zhou J; Xie W
    Mol Pharm; 2008; 5(1):60-6. PubMed ID: 18072748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice.
    Sugizaki T; Watanabe M; Horai Y; Kaneko-Iwasaki N; Arita E; Miyazaki T; Morimoto K; Honda A; Irie J; Itoh H
    Endocrinology; 2014 Aug; 155(8):2810-9. PubMed ID: 24773344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting orphan nuclear receptor SHP in the treatment of metabolic diseases.
    Kim MK; Chanda D; Lee IK; Choi HS; Park KG
    Expert Opin Ther Targets; 2010 Apr; 14(4):453-66. PubMed ID: 20230197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production.
    Fowler AJ; Sheu MY; Schmuth M; Kao J; Fluhr JW; Rhein L; Collins JL; Willson TM; Mangelsdorf DJ; Elias PM; Feingold KR
    J Invest Dermatol; 2003 Feb; 120(2):246-55. PubMed ID: 12542530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orphan nuclear receptor small heterodimer partner represses hepatocyte nuclear factor 3/Foxa transactivation via inhibition of its DNA binding.
    Kim JY; Kim HJ; Kim KT; Park YY; Seong HA; Park KC; Lee IK; Ha H; Shong M; Park SC; Choi HS
    Mol Endocrinol; 2004 Dec; 18(12):2880-94. PubMed ID: 15358835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver X receptor is a regulator of orphan nuclear receptor NOR-1 gene transcription in adipocytes.
    Kumar N; Wang H; Liu D; Collins S
    Int J Obes (Lond); 2009 May; 33(5):519-24. PubMed ID: 19238156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective activation of liver X receptors by acanthoic acid-related diterpenes.
    Traves PG; Hortelano S; Zeini M; Chao TH; Lam T; Neuteboom ST; Theodorakis EA; Palladino MA; Castrillo A; Bosca L
    Mol Pharmacol; 2007 Jun; 71(6):1545-53. PubMed ID: 17329499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
    Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
    Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear receptor subfamily 5 group A member 2 (NR5A2): role in health and diseases.
    Sandhu N; Rana S; Meena K
    Mol Biol Rep; 2021 Dec; 48(12):8155-8170. PubMed ID: 34643922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities.
    Jakobsson T; Treuter E; Gustafsson JÅ; Steffensen KR
    Trends Pharmacol Sci; 2012 Jul; 33(7):394-404. PubMed ID: 22541735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.
    Beaven SW; Tontonoz P
    Annu Rev Med; 2006; 57():313-29. PubMed ID: 16409152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice.
    Han SI; Komatsu Y; Murayama A; Steffensen KR; Nakagawa Y; Nakajima Y; Suzuki M; Oie S; Parini P; Vedin LL; Kishimoto H; Shimano H; Gustafsson JÅ; Yanagisawa J
    Hepatology; 2014 May; 59(5):1791-802. PubMed ID: 24277692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice.
    Grefhorst A; van Dijk TH; Hammer A; van der Sluijs FH; Havinga R; Havekes LM; Romijn JA; Groot PH; Reijngoud DJ; Kuipers F
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E829-38. PubMed ID: 15941783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A lipid to treat non-alcoholic fatty liver disease - the dawn of 'lipo-rehabilitation'?
    Anstee QM; Day CP
    J Hepatol; 2012 Apr; 56(4):987-9. PubMed ID: 22015962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer.
    Garattini E; Bolis M; Gianni' M; Paroni G; Fratelli M; Terao M
    Oncotarget; 2016 Jul; 7(27):42661-42682. PubMed ID: 26894976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.